Rapid identification of Candida spp. in peritonitis patients by Raman spectroscopy.

This prospective study evaluated Raman spectroscopy for the identification of clinically relevant Candida spp. in peritonitis patients. A Raman database was developed by measuring spectra from 93 reference strains belonging to ten different Candida spp. Clinical samples were obtained from the surgical department and intensive care unit of a tertiary university hospital. In total, 88 peritoneal specimens from 45 patients with primary, secondary or tertiary peritonitis were included. Specimens were cultured initially on a selective Sabouraud medium that contained gentamicin to suppress bacterial growth. For conventional identification, a chromogenic medium was used for presumptive identification, followed by use of the Vitek 2 system for definitive identification (requiring a total time of 48-96 h). Raman measurements were taken on overnight cultures from Sabouraud-gentamicin medium. Thirty-one samples were positive for Candida by culture. Using multivariate statistical analyses, a prediction accuracy of 90% was obtained for Raman spectroscopy, which appears to offer an accurate and rapid (12-24 h) alternative for the identification of Candida spp. in peritonitis patients. The reduced turn-around time is of great clinical importance for the treatment of critically ill patients with invasive candidiasis in intensive care units.

[1]  J. Heelan,et al.  Comparison of the Rapid Yeast Plus Panel with the API20C Yeast System for Identification of Clinically Significant Isolates of Candida Species , 1998, Journal of Clinical Microbiology.

[2]  A. Callow,et al.  Candida Infections in Surgical Patients , 1983, Annals of surgery.

[3]  K. Giercksky,et al.  Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. , 2002, Critical care medicine.

[4]  P. Francioli,et al.  Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. , 1999, Critical care medicine.

[5]  A. Sitges-Serra,et al.  Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy , 1997, Intensive Care Medicine.

[6]  J. Marshall,et al.  Tertiary Peritonitis: Clinical Features of a Complex Nosocomial Infection , 1993, World Journal of Surgery.

[7]  J. Kellogg,et al.  Limitations of the Current Microbial Identification System for Identification of Clinical Yeast Isolates , 1998, Journal of Clinical Microbiology.

[8]  R. L. Simmons,et al.  The role of Candida in intraperitoneal infections. , 1980, Surgery.

[9]  E. Bouza,et al.  Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. , 2000, International journal of antimicrobial agents.

[10]  R. Weinstein,et al.  Prophylactic antifungal therapy in the intensive care unit. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  K. Hazen,et al.  New and emerging yeast pathogens , 1995, Clinical microbiology reviews.

[12]  U. Göbel,et al.  Evaluation of the VITEK 2 System for Rapid Identification of Yeasts and Yeast-Like Organisms , 2000, Journal of Clinical Microbiology.

[13]  R F Woolson,et al.  Hospital-acquired candidemia. The attributable mortality and excess length of stay. , 1988, Archives of internal medicine.

[14]  G Sherman,et al.  The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.

[15]  M. Levenstein,et al.  A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia , 1994 .

[16]  H. Bruining,et al.  Rapid Identification of Candida Species by Confocal Raman Microspectroscopy , 2002, Journal of Clinical Microbiology.

[17]  P. Lipsett,et al.  Double-Blind Placebo-Controlled Trial of Fluconazole to Prevent Candidal Infections in Critically Ill Surgical Patients , 2001, Annals of surgery.

[18]  A. Freydiere,et al.  Yeast identification in the clinical microbiology laboratory: phenotypical methods. , 2001, Medical mycology.

[19]  J. Meis,et al.  Comparative study of seven commercial yeast identification systems. , 1999, Journal of clinical pathology.

[20]  D. Denning,et al.  Management of deepCandida infection in surgical and intensive care unit patients , 1994, Intensive Care Medicine.

[21]  L. See,et al.  Candida peritonitis due to peptic ulcer perforation: incidence rate, risk factors, prognosis and susceptibility to fluconazole and amphotericin B. , 2002, Diagnostic microbiology and infectious disease.

[22]  Hajo A. Bruining,et al.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. , 1995 .

[23]  Michael Seibold,et al.  Evaluation of Phenotypic Markers for Selection and Identification of Candida dubliniensis , 2000, Journal of Clinical Microbiology.

[24]  E. Anaissie,et al.  Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  D. Snydman,et al.  The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. , 1996, The American journal of medicine.

[26]  R. Wenzel Nosocomial candidemia: risk factors and attributable mortality. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  J. Mantz,et al.  Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. , 2002, Archives of surgery.

[28]  Dieter Naumann,et al.  FT-IR spectroscopy and FT-Raman spectroscopy are powerful analytical tools for the non-invasive characterization of intact microbial cells , 1995 .

[29]  D. Sullivan,et al.  New monoclonal antibody specific for Candida albicans germ tube. , 2000, Journal of clinical microbiology.

[30]  J. Vincent,et al.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. , 1995, JAMA.

[31]  H. Bruining,et al.  Raman spectroscopic method for identification of clinically relevant microorganisms growing on solid culture medium. , 2000, Analytical chemistry.

[32]  H. Moecke,et al.  Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients , 1997, Intensive Care Medicine.

[33]  Ronald N. Jones,et al.  National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic. , 1998, Diagnostic microbiology and infectious disease.

[34]  Royston Goodacre,et al.  Rapid Differentiation of Closely RelatedCandida Species and Strains by Pyrolysis-Mass Spectrometry and Fourier Transform-Infrared Spectroscopy , 1998, Journal of Clinical Microbiology.

[35]  C. Beck-Sague,et al.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. , 1993, The Journal of infectious diseases.

[36]  P. Francioli,et al.  CLINICAL SIGNIFICANCE OF CANDIDA ISOLATED FROM PERITONEUM IN SURGICAL PATIENTS , 1989, The Lancet.

[37]  D. Coleman,et al.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. , 1995, Microbiology.

[38]  Patrick R. Murray,et al.  Candida, Cryptococcus, and other yeasts of medical importance. , 2006 .

[39]  Thomas Udelhoven,et al.  Development of a Hierarchical Classification System with Artificial Neural Networks and FT-IR Spectra for the Identification of Bacteria , 2000 .